TKTanishq Khurana

Tanishq Khurana

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tanishq Khurana has a total of 6 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Drug transport in spheroids on a microfluidic tumor-on-chip platform: An integrated computational and experimental study

    by Tanishq Khurana, Sachin Thomas, Swathi Sudhakar, Sean M. Edwards, Rachel N. Bearon, Kiran Raj M

    Quantitative prediction of drug transport in three-dimensional tumor spheroids is critical for the design and interpretation of microfluidic spheroid-on-chip assays under perfused conditions. However, this process is governed by coupled advection, diffusion, cellular uptake, and metabolism within structurally heterogeneous spheroid architectures, making accurate modeling challenging. Here, we present a mechanistic transport framework that integrates realistic spheroid geometries reconstructed from histological imaging. The model couples advection–diffusion in the surrounding microchannel with tissue-scale transport through a heterogeneous, densely packed spheroid microenvironment, together with membrane-limited cellular uptake and intracellular metabolic consumption. This formulation resolves spatiotemporal drug concentration distributions under both static and perfused conditions within a unified framework. High-resolution micro particle image velocimetry (micro-PIV) measurements, performed under matched flow conditions, quantify the velocity field and interfacial shear stresses around spheroids in microchannels, providing detailed experimental characterization of the external hydrodynamic environment. The simulated velocity fields were validated against corresponding micro-PIV measurements under matched perfusion conditions, demonstrating good agreement between the computational and experimental flow profiles. In addition, fluorescence-based drug uptake experiments in MG-63 spheroids under static and perfused conditions provided an experimental investigation of perfusion-enhanced transport behavior within the spheroid microenvironment. The combined computational and experimental analysis identifies distinct transport regimes governed by diffusion, perfusion, and cellular metabolism, wherein micro-PIV measurements define the perfusion conditions for the transport analysis, while the computational model reveals how controlled microfluidic perfusion shapes intratumoral concentration gradients and penetration behavior. By directly linking spheroid-scale transport behavior with externally imposed microfluidic flow conditions, the framework provides a mechanistic basis for investigating physiologically relevant operating conditions in spheroid-on-chip systems relevant to microfluidic drug screening applications.


  • From microscale transport to data-driven intelligence: The convergence of microfluidics and machine learning

    by Tanishq Khurana, Sourav Ganguly, Kiran Raj M

    Microfluidics at its core is a multidisciplinary field that combines fluid mechanics, transport phenomena, and precision microfabrication to control fluid flows at the micrometer scale. Advances in design and fabrication, including soft lithography, photolithography, and advanced manufacturing techniques, have enabled highly integrated platforms for manipulating droplets, particles, and cells with remarkable precision, enabling quantitative characterization of microscale hydrodynamics, interfacial physics, and multiphase transport phenomena. In parallel, machine learning (ML) has emerged as a computational paradigm capable of extracting patterns, optimizing nonlinear systems, and performing predictive modeling on complex datasets. ML efficiently navigates the high-dimensional, multiphysics parameter spaces inherent to microfluidics, capturing couplings between flow and transport processes. This review highlights the fundamental convergence of microfluidics and ML, including physics-informed approaches that enable optimization grounded in physical principles, and presents recent advances connecting microscale transport phenomena with practical applications. ML-driven microfluidics enhances control across diverse systems, enabling systematic optimization of processes such as droplet generation, sorting, and mixing, while supporting diagnostic and therapeutic platforms. Predictive models further enable optimization of device operation and performance through the integration of mechanistic understanding with data-driven learning. We critically synthesize these advances, highlight emerging trends, and provide insights into future directions. While significant challenges remain, the convergence of microfluidics and ML is poised to enable self-optimizing devices, integrated closed-loop control, and adaptive operational strategies, transforming microfluidics into an intelligent, adaptive technology that bridges fundamental fluid mechanics and microscale transport phenomena with biomedical and engineering applications.

  • Intelligent organ-on-chip platforms: Machine learning in predictive and personalized drug delivery

    by Tanishq Khurana, Sourav Ganguly, Kiran Raj M

    The pursuit of physiologically relevant preclinical models has driven the emergence of three-dimensional tumor spheroids and organ-on-chip (OOC) platforms, which recapitulate the structural, biochemical, and functional complexity of human tissue microenvironments. Unlike conventional two-dimensional cultures and animal models, these systems provide human-specific insights into disease biology, drug delivery, and therapeutic response, addressing critical translational gaps in biomedical research. They reproduce cell–cell and cell–matrix interactions, vascularization, nutrient and drug gradients, and organ-level functions, offering new opportunities to evaluate drug penetration, efficacy, and safety. Their complexity generates high-dimensional imaging, omics, and functional datasets that are increasingly difficult to analyze using traditional approaches, setting the stage for the integration of artificial intelligence (AI) and machine learning (ML) as transformative tools. Recent advances demonstrate how AI-driven methods can automate spheroid image segmentation, quantify spatial heterogeneity, and extract predictive biomarkers of treatment response with minimal human bias. Deep learning algorithms are also being applied to predict drug transport dynamics, optimize dosing strategies, and analyze complex interactions within OOC systems, enhancing experimental precision and translational relevance. Moreover, AI integration with Multi-OOC platforms is beginning to capture systemic pharmacokinetics and pharmacodynamics, linking in vitro performance with in vivo outcomes and reshaping drug delivery research by coupling biological fidelity with computational intelligence. This review critically analyzes AI-enhanced spheroid and OOC platforms for drug delivery, highlighting progress and key challenges, such as data standardization, interpretability, and reproducibility, while outlining future directions, including the convergence of digital twins, ML, and multi-scale modeling toward intelligent, personalized, and clinically translatable drug delivery systems.